Percutaneous coronary intervention (PCI) is a non-surgical procedure, in which a catheter is used to place stent to broaden the narrowed coronary arteries.
The rapid shift toward MIS and increase in the volume of PCI procedures will be one of the primary growth drivers for the global percutaneous coronary intervention (PCI) devices market till 2021.

The global Percutaneous Coronary Intervention (PCI) Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Percutaneous Coronary Intervention (PCI) Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Percutaneous Coronary Intervention (PCI) Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Percutaneous Coronary Intervention (PCI) Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Percutaneous Coronary Intervention (PCI) Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Boston Scientific
Abbott
Medtronic
Cordis
Terumo Medical
AMG International
ASAHI INTECC
B. Braun Melsungen
BioSensors
BIOTRONIK
BrosMed Medical
Claret Medical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Coronary Stents
PTCA Catheters
Coronary Guidewires
Embolic Protection Devices

Segment by Application
Hospitals
Cath Labs
ASCs